| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a0a5f764f9ace11af8bc66066fe21b60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_658df3b9d24eb5224b37aaf605741db6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7e7a82b18ce14403cf6fec5aa696fa4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_188b299330173212cb1557cd895cea9c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558 |
| filingDate |
2006-04-27^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03c3c3fc6db7af08e23131e17b5a1341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ed2a56311c928899b2a3512fa112eae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6150f49a3025da10d24a3ea8cc906889 |
| publicationDate |
2006-11-02^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006116631-A2 |
| titleOfInvention |
Cancer specific pcna isoform binding antibodies and uses thereof |
| abstract |
Antibodies specifically bind only to a cancer specific proliferating cell nuclear antigen (csPCNA) isoform and not to the non-malignant proliferating cell nuclear antigen (nmPCNA) isoform. Methods and compositions to detect the presence of csPCNA isoform are disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007098415-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010011890-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010011890-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8653039-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2913057-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007098415-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011076342-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9187526-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8278278-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3878444-A1 |
| priorityDate |
2005-04-27^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |